Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.

Literature DB >> 21948392

Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.

Abstract

Angiogenesis is the new blood vessels formation and is the critical event for the growth of malignant diseases and plays a key role in the development, invasion, and metastasis of malignant tumors. Epstein-Barr virus (EBV) is an important carcinogen causing to the some neoplastic disorders and lytically infected cells may contribute to the growth of EBV-associated malignancies, and this phenomenon is related with enhancing angiogenesis. Due to the strong cross-talk between angiogenesis and viral carcinogenesis and increased information about the angiogenesis and viral carcinogenesis in lymphomas, we need new therapeutic approaches to cases with lymphoma. Due to the strong cross-talk between angiogenesis and viral lymphomagenesis, this association was reviewed in this study.

Entities: Disease Species

Mesh：

Year: 2011 PMID： 21948392 DOI： 10.1007/s12032-011-0065-z

Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064

52 in total

1. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.

Authors: Alexander Claviez; Markus Tiemann; Heike Lüders; Matthias Krams; Reza Parwaresch; Günther Schellong; Wolfgang Dörffel
Journal: J Clin Oncol Date: 2005-06-20 Impact factor: 44.544

2. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.

Authors: Naohiro Wakisaka; Shigeyuki Murono; Tomokazu Yoshizaki; Mitsuru Furukawa; Joseph S Pagano
Journal: Cancer Res Date: 2002-11-01 Impact factor: 12.701

3. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.

Authors: Nozomi Niitsu; Masataka Okamato; Hirokazu Nakamine; Tadashi Yoshino; Jun-ichi Tamaru; Shigeo Nakamura; Masaki Higashihara; Masami Hirano
Journal: Eur J Haematol Date: 2002-02 Impact factor: 2.997

Review 4. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

Authors: J Ruan; K Hajjar; S Rafii; J P Leonard
Journal: Ann Oncol Date: 2008-12-16 Impact factor: 32.976

5. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.

Authors: Morton Coleman; Peter Martin; Jia Ruan; Richard Furman; Ruben Niesvizky; Rebecca Elstrom; Patricia George; Thomas P Kaufman; John P Leonard
Journal: Cancer Date: 2008-05-15 Impact factor: 6.860

6. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors: Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal: Clin Cancer Res Date: 2007-09-01 Impact factor: 12.531

Review 7. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.

Authors: Ash A Alizadeh; Ranjana H Advani
Journal: Clin Adv Hematol Oncol Date: 2008-12

Review 8. Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.

Authors: Hannah H Wong; Jun Wang
Journal: Leuk Lymphoma Date: 2009-03

9. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Authors: Takashi Oyama; Koichi Ichimura; Ritsuro Suzuki; Junji Suzumiya; Koichi Ohshima; Yasushi Yatabe; Takio Yokoi; Masaru Kojima; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Michinori Ogura; Hidehiko Saito; Yasuo Morishima; Shigeo Nakamura
Journal: Am J Surg Pathol Date: 2003-01 Impact factor: 6.394

10. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population.

Authors: T Kuze; N Nakamura; Y Hashimoto; Y Sasaki; M Abe
Journal: Jpn J Cancer Res Date: 2000-12

3 in total